Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Inotersen therapy of transthyretin amyloid cardiomyopathy.

Dasgupta NR, Rissing SM, Smith J, Jung J, Benson MD.

Amyloid. 2019 Nov 12:1-7. doi: 10.1080/13506129.2019.1685487. [Epub ahead of print]

PMID:
31713445
2.

Enhanced Interfacial Toughness of Thermoplastic-Epoxy Interfaces Using ALD Surface Treatments.

Chen Y, Ginga NJ, LePage WS, Kazyak E, Gayle AJ, Wang J, Rodríguez RE, Thouless MD, Dasgupta NP.

ACS Appl Mater Interfaces. 2019 Nov 8. doi: 10.1021/acsami.9b15193. [Epub ahead of print]

PMID:
31702884
3.

Increasing gender diversity in the STEM research workforce.

Greider CW, Sheltzer JM, Cantalupo NC, Copeland WB, Dasgupta N, Hopkins N, Jansen JM, Joshua-Tor L, McDowell GS, Metcalf JL, McLaughlin B, Olivarius A, O'Shea EK, Raymond JL, Ruebain D, Steitz JA, Stillman B, Tilghman SM, Valian V, Villa-Komaroff L, Wong JY.

Science. 2019 Nov 8;366(6466):692-695. doi: 10.1126/science.aaz0649. No abstract available.

PMID:
31699926
4.

Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease.

Thomas VE, Smith J, Benson MD, Dasgupta NR.

Neurodegener Dis Manag. 2019 Nov 5. doi: 10.2217/nmt-2019-0020. [Epub ahead of print]

PMID:
31686587
5.

An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study.

Black JC, Rockhill K, Forber A, Amioka E, May KP, Haynes CM, Dasgupta N, Dart RC.

J Med Internet Res. 2019 Oct 25;21(10):e15830. doi: 10.2196/15830.

6.

Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells.

Woodle ES, Tremblay S, Brailey P, Girnita A, Alloway RR, Aronow B, Dasgupta N, Ebstein F, Kloetzel PM, Lee MJ, Kim KB, Singh H, Driscoll JJ.

Am J Transplant. 2019 Oct 8. doi: 10.1111/ajt.15634. [Epub ahead of print]

PMID:
31595669
7.

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.

van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O, Dasgupta N, Dietrich J, Gama S, Lewis D, Newbould V, Brosch S, Pierce CE, Powell G, Ptaszyńska-Neophytou A, Wiśniewski AFZ, Tregunno P, Norén GN, Pirmohamed M.

Drug Saf. 2019 Aug 24. doi: 10.1007/s40264-019-00858-7. [Epub ahead of print]

PMID:
31446567
8.

Direct comparison of additively manufactured porous titanium and tantalum implants towards in vivo osseointegration.

Bandyopadhyay A, Mitra I, Shivaram A, Dasgupta N, Bose S.

Addit Manuf. 2019 Aug;28:259-266. doi: 10.1016/j.addma.2019.04.025. Epub 2019 May 1.

PMID:
31406683
9.

Postsurgical Opioid Prescriptions and Risk of Long-term Use: An Observational Cohort Study Across the United States.

Young JC, Dasgupta N, Chidgey BA, Jonsson Funk M.

Ann Surg. 2019 Aug 9. doi: 10.1097/SLA.0000000000003549. [Epub ahead of print]

PMID:
31404007
10.

Treatment of ATTR cardiomyopathy with a TTR specific antisense oligonucleotide, inotersen.

Dasgupta NR, Benson MD.

Amyloid. 2019;26(sup1):20-21. doi: 10.1080/13506129.2019.1582490. No abstract available.

PMID:
31343363
11.

ALECT2 and NASH.

Cummings OW, Dasgupta NR, Benson MD.

Amyloid. 2019;26(sup1):158-159. doi: 10.1080/13506129.2019.1584099. No abstract available.

PMID:
31343321
12.

Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States.

Young JC, Jonsson Funk M, Dasgupta N.

Pain Med. 2019 Jul 24. pii: pnz155. doi: 10.1093/pm/pnz155. [Epub ahead of print]

PMID:
31340004
13.

Erratum: Author Correction: Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts.

Patel R, Belousov M, Jani M, Dasgupta N, Winokur C, Nenadic G, Dixon WG.

NPJ Digit Med. 2018 Jul 9;1:28. doi: 10.1038/s41746-018-0037-1. eCollection 2018.

14.

Burden of hereditary transthyretin amyloidosis on quality of life.

Yarlas A, Gertz MA, Dasgupta NR, Obici L, Pollock M, Ackermann EJ, Lovley A, Kessler AS, Patel PA, White MK, Guthrie SD.

Muscle Nerve. 2019 Aug;60(2):169-175. doi: 10.1002/mus.26515. Epub 2019 Jun 13.

15.

Cryoablation of low-flow vascular malformations.

Ramaswamy RS, Tiwari T, Darcy MD, Kim SK, Akinwande O, Dasgupta N, Guevara CJ.

Diagn Interv Radiol. 2019 May;25(3):225-230. doi: 10.5152/dir.2019.18278.

16.

The HIRA histone chaperone complex subunit UBN1 harbors H3/H4- and DNA-binding activity.

Ricketts MD, Dasgupta N, Fan J, Han J, Gerace M, Tang Y, Black BE, Adams PD, Marmorstein R.

J Biol Chem. 2019 Jun 7;294(23):9239-9259. doi: 10.1074/jbc.RA119.007480. Epub 2019 Apr 30.

PMID:
31040182
17.

Assessment of Occupational Health Hazards Due to Particulate Matter Originated from Spices.

Upadhyay E, Mohammad AlMass AA, Dasgupta N, Rahman S, Kim J, Datta M.

Int J Environ Res Public Health. 2019 Apr 29;16(9). pii: E1519. doi: 10.3390/ijerph16091519. Review.

18.

Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.

Pierce CE, de Vries ST, Bodin-Parssinen S, Härmark L, Tregunno P, Lewis DJ, Maskell S, Van Eemeren R, Ptaszynska-Neophytou A, Newbould V, Dasgupta N, Wisniewski AFZ, Gama S, Mol PGM.

Drug Saf. 2019 Apr;42(4):477-489. doi: 10.1007/s40264-019-00813-6.

19.

Silver nanoparticles engineered by thermal co-reduction approach induces liver damage in Wistar rats: acute and sub-chronic toxicity analysis.

Dasgupta N, Ranjan S, Ramalingam C, Gandhi M.

3 Biotech. 2019 Apr;9(4):125. doi: 10.1007/s13205-019-1651-6. Epub 2019 Mar 6.

PMID:
30863704
20.

Development of the ReaxFF Methodology for Electrolyte-Water Systems.

Fedkin MV, Shin YK, Dasgupta N, Yeon J, Zhang W, van Duin D, van Duin ACT, Mori K, Fujiwara A, Machida M, Nakamura H, Okumura M.

J Phys Chem A. 2019 Mar 14;123(10):2125-2141. doi: 10.1021/acs.jpca.8b10453. Epub 2019 Mar 1.

PMID:
30775922
21.

Frequent discussion of insomnia and weight gain with glucocorticoid therapy: An analysis of Twitter posts.

Patel R, Belousov M, Jani M, Dasgupta N, Winokur C, Nenadic G, Dixon WG.

NPJ Digit Med. 2018 Feb 12;1. doi: 10.1038/s41746-017-0007-z. Erratum in: NPJ Digit Med. 2018 Jul 9;1:28.

22.

Causal inference for evaluating prescription opioid abuse using trend-in-trend design.

Dasgupta N, Schwarz J, Hennessy S, Ertefaie A, Dart RC.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):716-725. doi: 10.1002/pds.4736. Epub 2019 Feb 3.

PMID:
30714239
23.

The Forkhead box F1 transcription factor inhibits collagen deposition and accumulation of myofibroblasts during liver fibrosis.

Flood HM, Bolte C, Dasgupta N, Sharma A, Zhang Y, Gandhi CR, Kalin TV, Kalinichenko VV.

Biol Open. 2019 Feb 11;8(2). pii: bio039800. doi: 10.1242/bio.039800.

24.

Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009-2014.

Alexandridis AA, Dasgupta N, McCort AD, Ringwalt CL, Rosamond WD, Chelminski PR, Marshall SW.

Inj Epidemiol. 2019 Jan 21;6(1):2. doi: 10.1186/s40621-018-0179-2.

25.

MIPS: Functional dynamics in evolutionary pathways of plant kingdom.

Hazra A, Dasgupta N, Sengupta C, Das S.

Genomics. 2019 Jan 17. pii: S0888-7543(18)30416-6. doi: 10.1016/j.ygeno.2019.01.004. [Epub ahead of print]

PMID:
30660787
26.

The lipidome of Thoroughbred racehorses before and after supramaximal exercise.

Nolazco Sassot L, Villarino NF, Dasgupta N, Morrison JJ, Bayly WM, Gang D, Sanz MG.

Equine Vet J. 2019 Sep;51(5):696-700. doi: 10.1111/evj.13064. Epub 2019 Feb 9.

PMID:
30600546
27.

Inotersen (transthyretin-specific antisense oligonucleotide) for treatment of transthyretin amyloidosis.

Benson MD, Dasgupta NR, Monia BP.

Neurodegener Dis Manag. 2019 Feb;9(1):25-30. doi: 10.2217/nmt-2018-0037. Epub 2018 Dec 18.

PMID:
30561247
28.

Butyrate-Induced In Vitro Colonocyte Differentiation Network Model Identifies ITGB1, SYK, CDKN2A, CHAF1A, and LRP1 as the Prognostic Markers for Colorectal Cancer Recurrence.

Dasgupta N, Kumar Thakur B, Chakraborty A, Das S.

Nutr Cancer. 2019;71(2):257-271. doi: 10.1080/01635581.2018.1540715. Epub 2018 Nov 26.

PMID:
30475060
29.

Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006-2016.

Iwanicki JL, Severtson SG, Margolin Z, Dasgupta N, Green JL, Dart RC.

Am J Public Health. 2018 Dec;108(12):1639-1645. doi: 10.2105/AJPH.2018.304728.

30.

Bioinspired gold nanoparticles decorated reduced graphene oxide nanocomposite using Syzygium cumini seed extract: Evaluation of its biological applications.

Kadiyala NK, Mandal BK, Ranjan S, Dasgupta N.

Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:191-205. doi: 10.1016/j.msec.2018.07.075. Epub 2018 Jul 29.

PMID:
30274051
31.

Effect of Threat and Social Identity on Reactions to Ingroup Criticism: Defensiveness, Openness, and a Remedy.

Adelman L, Dasgupta N.

Pers Soc Psychol Bull. 2019 May;45(5):740-753. doi: 10.1177/0146167218796785. Epub 2018 Sep 29.

PMID:
30270735
32.

Author Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.

Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B.

Nat Cell Biol. 2018 Nov;20(11):1328. doi: 10.1038/s41556-018-0203-3.

PMID:
30190576
33.

Hypoxia-induced Pulmonary Hypertension in Different Mouse Strains: Relation to Transcriptome.

Ikeda KT, Hale PT, Pauciulo MW, Dasgupta N, Pastura PA, Le Cras TD, Pandey MK, Nichols WC.

Am J Respir Cell Mol Biol. 2019 Jan;60(1):106-116. doi: 10.1165/rcmb.2017-0435OC.

PMID:
30134121
34.

Publisher Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.

Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B.

Nat Cell Biol. 2018 Oct;20(10):1228. doi: 10.1038/s41556-018-0185-1.

PMID:
30089841
35.

"He Is the Object of Information": The Intersection of Big Data and the Opioid Crisis.

Dasgupta N.

Am J Public Health. 2018 Sep;108(9):1122-1123. doi: 10.2105/AJPH.2018.304601. No abstract available.

PMID:
30089004
36.

Thermal Co-reduction engineered silver nanoparticles induce oxidative cell damage in human colon cancer cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis.

Dasgupta N, Ranjan S, Mishra D, Ramalingam C.

Chem Biol Interact. 2018 Nov 1;295:109-118. doi: 10.1016/j.cbi.2018.07.028. Epub 2018 Jul 27.

PMID:
30056045
37.

Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".

Dasgupta N, Saucier R, Wolfe D.

Drug Saf. 2018 Oct;41(10):995-997. doi: 10.1007/s40264-018-0692-9. No abstract available.

PMID:
29956219
38.

AMP kinase promotes glioblastoma bioenergetics and tumour growth.

Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B.

Nat Cell Biol. 2018 Jul;20(7):823-835. doi: 10.1038/s41556-018-0126-z. Epub 2018 Jun 18. Erratum in: Nat Cell Biol. 2018 Aug 8;:. Nat Cell Biol. 2018 Nov;20(11):1328.

39.

Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids.

Young JC, Lund JL, Dasgupta N, Jonsson Funk M.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):39-47. doi: 10.1002/pds.4572. Epub 2018 Jun 11.

PMID:
29888409
40.

Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base.

Ranapurwala SI, Naumann RB, Austin AE, Dasgupta N, Marshall SW.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):4-12. doi: 10.1002/pds.4564. Epub 2018 Jun 3. Review.

PMID:
29862602
41.

Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.

Saucier R, Wolfe D, Dasgupta N.

Drug Saf. 2018 Oct;41(10):989. doi: 10.1007/s40264-018-0685-8.

PMID:
29796833
42.

Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone.

Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):25-30. doi: 10.1002/pds.4558. Epub 2018 May 15.

PMID:
29766592
43.

An optimal set of features for predicting type IV secretion system effector proteins for a subset of species based on a multi-level feature selection approach.

Esna Ashari Z, Dasgupta N, Brayton KA, Broschat SL.

PLoS One. 2018 May 9;13(5):e0197041. doi: 10.1371/journal.pone.0197041. eCollection 2018.

44.

Observation of a new pattern of mutations in gyrA and parC within Escherichia coli exhibiting fluroquinolone resistance.

Dasgupta N, Paul D, Chanda DD, Chetri S, Chakravarty A, Bhattacharjee A.

Indian J Med Microbiol. 2018 Jan-Mar;36(1):131-135. doi: 10.4103/ijmm.IJMM_17_181.

45.

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

Schafer C, Moore V, Dasgupta N, Javadov S, James JF, Glukhov AI, Strauss AW, Khuchua Z.

Front Pharmacol. 2018 Apr 11;9:318. doi: 10.3389/fphar.2018.00318. eCollection 2018.

46.

Formulation of vitamin D encapsulated cinnamon oil nanoemulsion: Its potential anti-cancerous activity in human alveolar carcinoma cells.

Meghani N, Patel P, Kansara K, Ranjan S, Dasgupta N, Ramalingam C, Kumar A.

Colloids Surf B Biointerfaces. 2018 Jun 1;166:349-357. doi: 10.1016/j.colsurfb.2018.03.041. Epub 2018 Mar 27.

PMID:
29631227
47.

Titanium dioxide nanoparticle-protein interaction explained by docking approach.

Ranjan S, Dasgupta N, Sudandiradoss C, Ramalingam C, Kumar A.

Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):47-50. doi: 10.2147/IJN.S125008. eCollection 2018.

48.

Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.

Murphy DL, Lebin JA, Severtson SG, Olsen HA, Dasgupta N, Dart RC.

Drug Saf. 2018 Aug;41(8):787-795. doi: 10.1007/s40264-018-0660-4.

PMID:
29582394
49.

Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.

Saucier R, Wolfe D, Dasgupta N.

Drug Saf. 2018 Oct;41(10):981-988. doi: 10.1007/s40264-018-0653-3. Erratum in: Drug Saf. 2018 May 24;:.

PMID:
29560596
50.

Community Readiness to Prevent Opioid Overdose.

Ringwalt C, Sanford C, Dasgupta N, Alexandridis A, McCort A, Proescholdbell S, Sachdeva N, Mack K.

Health Promot Pract. 2018 Sep;19(5):747-755. doi: 10.1177/1524839918756887. Epub 2018 Feb 5.

Supplemental Content

Loading ...
Support Center